3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hodgkin Disease
6
Neoplasms
2
Melanoma, Cutaneous Malignant
1
Melanoma
1
Lung Neoplasms
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Kidney Neoplasms
1
Colonic Neoplasms
1
Breast Neoplasms
1
Advanced Melanoma
1
Interventions
Carboplatin
14
Etoposide
13
Topotecan
8
durvalumab
7
atezolizumab
7
Specimen Handling
7
Cisplatin
6
PM 01183
5
pembrolizumab
4
Magnetic Resonance Spectroscopy
4
Irinotecan
4
Injections
3
Biopsy
3
olaparib
2
berzosertib
2
Radiotherapy
2
Nivolumab
2
Fulvestrant
2
AMG 757
2
tremelimumab
1
trastuzumab deruxtecan
1
toripalimab
1
tazemetostat
1
sugemalimab
1
palbociclib
1
lenvatinib
1
fludarabine
1
enzalutamide
1
cabozantinib
1
budigalimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Small Cell Lung Carcinoma
×
Dacarbazine
×
30 days
×
Clear all
No trials found.